Geron Corporation (GERN): Price and Financial Metrics
Geron Corporation (GERN)
Today's Latest Price: $1.69 USD
0.01 (0.60%)
Updated Sep 25 4:00pm
Add GERN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
GERN Stock Summary
- GERN's price/sales ratio is 1,321.64; that's higher than the P/S ratio of 99.52% of US stocks.
- With a year-over-year growth in debt of 1,354.48%, Geron Corp's debt growth rate surpasses 98.47% of about US stocks.
- Revenue growth over the past 12 months for Geron Corp comes in at -43.12%, a number that bests only 4.99% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Geron Corp are CBMG, INO, MRSN, ARNA, and PTN.
- Visit GERN's SEC page to see the company's official filings. To visit the company's web site, go to www.geron.com.
GERN Daily Price Range
GERN 52-Week Price Range
GERN Stock Price Chart Technical Analysis Charts
GERN Price/Volume Stats
| Current price | $1.69 | 52-week high | $2.40 |
| Prev. close | $1.68 | 52-week low | $0.75 |
| Day low | $1.67 | Volume | 2,101,535 |
| Day high | $1.72 | Avg. volume | 2,645,434 |
| 50-day MA | $1.80 | Dividend yield | N/A |
| 200-day MA | $1.52 | Market Cap | 524.69M |
Geron Corporation (GERN) Company Bio
Geron Corporation focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Loading social stream, please wait...